ArticleAnales del sistema sanitario de Navarra2025
[Cannabinoid content in seized hashish joints from Castilla y León (Spain)].
Article in Anales del sistema sanitario de Navarra, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCannabis, in both its herbal form and resin-derived products, is the most widely consumed illicit drug worldwide. This study aimed to determine the potency and dosage of the primary cannabinoids present in cannabis resin from joints circulating in the region.
methodsA descriptive study was conducted on seized joints confiscated by law enforcement agencies in the Autonomous Community of Castilla y León (Spain) between 2017 and 2020. Gross (whole joint) and net (filler) weights were recorded. Gas chromatography was used to quantify cannabinoids delta-9-tetrahydrocannabinol, cannabidiol, and cannabinol. Potency (percentage content) and dosage (mg) were calculated and bioavailability was estimated at 10% and 25%.
resultsA total of 639 joints containing a mixture of cannabis resin and tobacco were analyzed (34.3% of confiscated samples). Both gross and net weights showed a decreasing trend over time (6.5-8.5%). Median potency values for delta-9-tetrahydrocannabinol, cannabidiol, and cannabinol were 7.58%, 0.62%, and 0.60%, respectively, while corresponding dosages were 57.04 mg, 4.57 mg, and 4.46 mg. Overall potency and dosage declined across the study period for THC (13.5%), CBN (73%) and CBD (52-67%).
conclusionsThe delta-9-tetrahydrocannabinol potency and dosage found in confiscated cannabis resin joints during the study period were higher than those typically reported for herbal cannabis joints, suggesting greater user exposure and increased potential health risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.